Paul Gordon

发表

Infantile Fibrosarcoma With NTRK3–ETV6 Fusion Successfully Treated With the Tropomyosin‐Related Kinase Inhibitor LOXO‐101

A. Pappo, J. Rastatter, M. Cox, 2016, Pediatric blood & cancer.

A Next-Generation TRK Kinase Inhibitor Overcomes Acquired Resistance to Prior TRK Kinase Inhibition in Patients with TRK Fusion-Positive Solid Tumors.

B. Taylor, M. Berger, A. Drilon, 2017, Cancer discovery.

Safety and Efficacy of Subcutaneous (SC) Blinatumomab for the Treatment of Adults with Relapsed or Refractory B Cell Precursor Acute Lymphoblastic Leukemia (R/R B-ALL)

B. Panwar, J. Hernández-Rivas, G. Rossi, 2021, Blood.

Single agent subcutaneous blinatumomab for advanced acute lymphoblastic leukemia.

J. Hernández-Rivas, G. Zugmaier, C. Berthon, 2024, American journal of hematology.